Table 4.
Differences between patients with and without dementia in the COVID-19 group, not adjusted for sex or age. Analysed with chi-2 test
| Characteristics | Dementia | No dementia | χ2 | P-value |
|---|---|---|---|---|
| Breathlessness occurrencea | 60/93 (65%) | 893/1231 (73%) | 2.8 | .097 |
| Anxiety occurrencea | 47/80 (59%) | 778/1109 (70%) | 4.6 | .033 |
| Delirium occurrencea | 47/83 (57%) | 386/1007 (38%) | 10.7 | .001 |
| Respiratory secretions occurrencea | 36/98 (37%) | 595/1259 (47%) | 4.0 | .044 |
| Nausea occurrencea | 6/80 (8%) | 94/942 (10%) | 0.5 | .47 |
| Pain occurrencea | 59/92 (64%) | 727/1191 (61%) | 0.3 | .56 |
| Close friend(s) and/or relative(s) present with or without staff at the time of deatha | 23/99 (23%) | 343/1320 (26%) | 0.4 | .55 |
| Someone present at the time of deatha | 49/99 (50%) | 756/1320 (57%) | 2.3 | .13 |
| Parenteral fluids/nutrition or enteral-tube feeding given during the last 24 hoursa | 31/100 (31%) | 504/1333 (38%) | 1.8 | .18 |
a“Don’t know” was an optional answer for the questions on symptom occurrence, and these responses were excluded from the analysis. Therefore, numbers do not sum to group totals